Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Implant-associated infections are caused by microorganisms growing in biofilms, rendering these infections difficult to diagnose and to eradicate. Delayed-onset low-grade infection is difficult to distinguish from aseptic failure, often presenting without signs of infection, but only with early loosening and persisting pain. A combination of criteria is needed for an accurate diagnosis: clinical signs and symptoms, laboratory signs of infection, microbiology, histology, and imaging. The treatment goals in prosthetic joint-associated infection are eradication of infection and an optimal functional result. The goal in internal fixation device-associated infection is consolidation of the fracture and avoidance of chronic osteomyelitis. Successful treatment requires an adequate surgical procedure combined with long-term antimicrobial therapy, ideally with an agent acting on adhering biofilm microorganisms. This article reviews the epidemiology, pathogenesis, diagnosis, and management of implant-associated infections, and presents pathogenesis and risk of hematogenous infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. del Pozo JL, Patel R: The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 2007, 82:204–209.

    Article  PubMed  Google Scholar 

  2. Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med 2004, 351:1645–1654.

    Article  PubMed  CAS  Google Scholar 

  3. Steckelberg JM, Osmon DR: Prosthetic joint infection. In: Infections Associated with Indwelling Medical Devices, edn 3. Edited by Bisno AL, Waldvogel FA. Washington, DC: American Society for Microbiology; 2000:173–209.

    Google Scholar 

  4. Donlan RM: Biofilms: Microbial life on surfaces. Emerg Infect Dis 2002, 8:881–890.

    PubMed  Google Scholar 

  5. Ochsner PE, Sirkin MS, Trampuz A: Acute infection. In: Principles of Fracture Management. Edited by Ruedi RP, Murphy WM. Stuttgart, Germany: Thieme Verlag; 2006.

    Google Scholar 

  6. Trampuz A, Hanssen AD, Osmon DR, et al.: Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 2004, 117:556–562.

    Article  PubMed  Google Scholar 

  7. Trampuz A, Piper KE, Hanssen AD, et al.: Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol 2006, 44:628–631.

    Article  PubMed  Google Scholar 

  8. Dora C, Altwegg M, Gerber C, et al.: Evaluation of conventional microbiological procedures and molecular genetic techniques for diagnosis of infections in patients with implanted orthopedic devices. J Clin Microbiol 2008, 46:824–825.

    Article  PubMed  CAS  Google Scholar 

  9. Esteban J, Gomez-Barrena E, Cordero J, et al.: Evaluation of quantitative analysis of cultures from sonicated retrieved orthopedic implants in diagnosis of orthopedic infection. J Clin Microbiol 2008, 46:488–492.

    Article  PubMed  Google Scholar 

  10. Trampuz A, Piper KE, Jacobson MJ, et al.: Sonication of removed hip and knee prostheses for improved diagnosis of infection. N Engl J Med 2007, 357:654–663.

    Article  PubMed  CAS  Google Scholar 

  11. Trampuz A, Osmon DR, Hanssen AD, et al.: Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop 2003, 414:69–88.

    Article  PubMed  Google Scholar 

  12. Smith SL, Wastie ML, Forster I: Radionuclide bone scintigraphy in the detection of significant complications after total knee joint replacement. Clin Radiol 2001, 56:221–224.

    Article  PubMed  CAS  Google Scholar 

  13. Sonmezoglu K, Sonmezoglu M, Halac M, et al.: Usefulness of 99mTc-ciprofloxacin (Infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med 2001, 42:567–574.

    PubMed  CAS  Google Scholar 

  14. Ivancevic V, Perka C, Hasart O, et al.: Imaging of low-grade bone infection with a technetium-99m labelled monoclonal anti-NCA-90 Fab’ fragment in patients with previous joint surgery. Eur J Nucl Med Mol Imaging 2002, 29:547–551.

    Article  PubMed  CAS  Google Scholar 

  15. Love C, Marwin SE, Tomas MB, et al.: Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J Nucl Med 2004, 45:1864–1871.

    PubMed  Google Scholar 

  16. Stumpe KD, Notzli HP, Zanetti M, et al.: FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 2004, 231:333–341.

    Article  PubMed  Google Scholar 

  17. Cheung A, Lachiewicz PF, Renner JB: The role of aspiration and contrast-enhanced arthrography in evaluating the uncemented hip arthroplasty. AJR Am J Roentgenol 1997, 168:1305–1309.

    PubMed  CAS  Google Scholar 

  18. Brause BD: Infections with prostheses in bones and joints. In: Principles and Practice of Infectious Diseases, edn 6. Edited by Mandell GL, Bennett JE, Dolin R. New York: Elsevier, Churchill, Livingstone; 2005:1332–1337.

    Google Scholar 

  19. Widmer AF, Frei R, Rajacic Z, Zimmerli W: Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990, 162:96–102.

    PubMed  CAS  Google Scholar 

  20. Widmer AF, Wiestner A, Frei R, Zimmerli W: Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991, 35:741–746.

    PubMed  CAS  Google Scholar 

  21. Zimmerli W, Frei R, Widmer AF, Rajacic Z: Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994, 33:959–967.

    Article  PubMed  CAS  Google Scholar 

  22. Zimmerli W, Widmer AF, Blatter M, et al.: Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998, 279:1537–1541.

    Article  PubMed  CAS  Google Scholar 

  23. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W: Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992, 14:1251–1253.

    PubMed  CAS  Google Scholar 

  24. Trebse R, Pisot V, Trampuz A: Treatment of infected retained implants. J Bone Joint Surg Br 2005, 87B:249–256.

    Google Scholar 

  25. Giulieri SG, Graber P, Ochsner PE, Zimmerli W: Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004, 32:222–228.

    Article  PubMed  CAS  Google Scholar 

  26. Laffer RR, Graber P, Ochsner PE, Zimmerli W: Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006, 12:433–439.

    Article  PubMed  CAS  Google Scholar 

  27. Betsch BY, Eggli S, Siebenrock KA, et al.: Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008, 46:1221–1226.

    Article  PubMed  Google Scholar 

  28. Brandt CM, Sistrunk WW, Duffy MC, et al.: Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997, 24:914–919.

    PubMed  CAS  Google Scholar 

  29. Tsukayama DT, Wicklund B, Gustilo RB: Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 1991, 14:841–844.

    PubMed  CAS  Google Scholar 

  30. Crockarell JR, Hanssen AD, Osmon DR, Morrey BF: Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998, 80:1306–1313.

    PubMed  CAS  Google Scholar 

  31. Marculescu CE, Berbari EF, Hanssen AD, et al.: Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006, 42:471–478.

    Article  PubMed  CAS  Google Scholar 

  32. Ure KJ, Amstutz HC, Nasser S, Schmalzried TP: Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 1998, 80:961–968.

    PubMed  CAS  Google Scholar 

  33. Raut VV, Siney PD, Wroblewski BM: One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br 1994, 76:721–724.

    PubMed  CAS  Google Scholar 

  34. Sendi P, Rohrbach M, Graber P, et al.: Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 2006, 43:961–967.

    Article  PubMed  Google Scholar 

  35. Langlais F: Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Br 2003, 85:637–640.

    PubMed  Google Scholar 

  36. van de BH, Neut D, Schenk W, et al.: Staphylococcus aureus biofilm formation on different gentamicin-loaded polymethylmethacrylate bone cements. Biomaterials 2001, 22:1607–1611.

    Article  Google Scholar 

  37. Josefsson G, Gudmundsson G, Kolmert L, Wijkstrom S: Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty. A five-year survey of 1688 hips. Clin Orthop Relat Res 1990, 173–178.

  38. Trampuz A, Zimmerli W: Diagnosis and treatment of infections associated with fracture-fixation devices. Injury 2006, 37:S59–S66.

    Article  PubMed  Google Scholar 

  39. Trampuz A, Murphy CK, Rothstein DM, et al.: Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection. Antimicrob Agents Chemother 2007, 51:2540–2545.

    Article  PubMed  CAS  Google Scholar 

  40. Robertson GT, Bonventre EJ, Doyle TB, et al.: In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus. Antimicrob Agents Chemother 2008 (Epub ahead of print).

  41. Shirtliff ME, Calhoun JH, Mader JT: Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits. J Antimicrob Chemother 2001, 48:253–258.

    Article  PubMed  CAS  Google Scholar 

  42. Soriano A, Gomez J, Gomez L, et al.: Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis 2007, 26:353–356.

    Article  PubMed  CAS  Google Scholar 

  43. Bressler AM, Zimmer SM, Gilmore JL, Somani J: Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect Dis 2004, 4:528–531.

    Article  PubMed  Google Scholar 

  44. Zimmerli W, Ochsner PE: Management of infection associated with prosthetic joints. Infection 2003, 31:99–108.

    Article  PubMed  CAS  Google Scholar 

  45. Carpenter CF, Chambers HF: Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis 2004, 38:994–1000.

    Article  PubMed  CAS  Google Scholar 

  46. Rao N, Regalla DM: Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series. Clin Orthop 2006, 451:34–37.

    Article  PubMed  Google Scholar 

  47. Maderazo EG, Judson S, Pasternak H: Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop 1988, 299:131–142.

    Google Scholar 

  48. Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE: Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982, 146:487–497.

    PubMed  CAS  Google Scholar 

  49. Zimmerli W, Lew PD, Waldvogel FA: Pathogenesis of foreign body infection: evidence for a local granulocyte defect. J Clin Invest 1984, 73:1191–1200.

    Article  PubMed  CAS  Google Scholar 

  50. Elek SD, Conen PE: The virulence of Staphylococcus pyogenes for man; a study of the problem of wound infection. Br J Exp Pathol 1957, 38:573–586.

    PubMed  CAS  Google Scholar 

  51. Lucas VS, Lytra V, Hassan T, et al.: Comparison of lysis filtration and an automated blood culture system (BACTEC) for detection, quantification, and identification of odontogenic bacteremia in children. J Clin Microbiol 2002, 40:3416–3420.

    Article  PubMed  Google Scholar 

  52. Coulter WA, Coffey A, Saunders ID, Emmerson AM: Bacteremia in children following dental extraction. J Dent Res 1990, 69:1691–1695.

    PubMed  CAS  Google Scholar 

  53. Zimmerli W, Zak O, Vosbeck K: Experimental hematogenous infection of subcutaneously implanted foreign bodies. Scand J Infect Dis 1985, 17:303–310.

    PubMed  CAS  Google Scholar 

  54. Blomgren G, Lundquist H, Nord CE, Lindgren U: Late anaerobic haematogenous infection of experimental total joint replacement. A study in the rabbit using Propionibacterium acnes. J Bone Joint Surg Br 1981, 63B:614–618.

    PubMed  CAS  Google Scholar 

  55. Deacon JM, Pagliaro AJ, Zelicof SB, Horowitz HW: Prophylactic use of antibiotics for procedures after total joint replacement. J Bone Joint Surg Am 1996, 78:1755–1770.

    PubMed  CAS  Google Scholar 

  56. Murdoch DR, Roberts SA, Fowler JV Jr, et al.: Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 2001, 32:647–649.

    Article  PubMed  CAS  Google Scholar 

  57. American Academy of Orthopaedic Surgeons: Antibiotic prophylaxis for dental patients with total joint replacements; 2004. [Information statement 1014.] Available at http://www.aaos.org/about/papers/advistmt/1014.asp. Accessed June 2008.

Download references

Author information

Authors and Affiliations

  1. Medical University Clinic, Kantonsspital, CH-4410, Liestal, Switzerland

    Werner Zimmerli

Authors
  1. Andrej Trampuz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Werner Zimmerli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Werner Zimmerli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trampuz, A., Zimmerli, W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep 10, 394–403 (2008). https://doi.org/10.1007/s11908-008-0064-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-008-0064-1

Keywords

Search

Navigation